Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    News Scan

    Biodefense Headlines – 22 November 2020

    By Global Biodefense StaffNovember 22, 2020
    Share
    Facebook LinkedIn Reddit Email

    News highlights on health security threats and countermeasures curated by Global Biodefense

    This week’s selections include the timeline for emergency use authorization of COVID-19 vaccines; virus-like particle vaccines against avian flu panzootic; and a call to act against Russia’s use of chemical weapons.

    Contents

    • PUBLIC HEALTH EMERGENCY
      • ‘No One Is Listening to Us’
      • Now the U.S. Has Lots of Ventilators, but Too Few Specialists to Operate Them
      • Microsoft: Russian, North Korean Hackers Target Vaccine Work
    • MEDICAL COUNTERMEASURES
      • Dec. 10 FDA Panel Could Be Gateway to First EUA of COVID-19 Vaccine
      • Virus-like Particle Vaccines: A Prospective Panacea Against an Avian Influenza Panzootic
      • Novavax Posts Massive Coronavirus Vaccine Contract That Government Didn’t Disclose
      • Feds Announce COVID-19 Vaccine Agreement with Drug Stores
      • Ebola-Negative Neonates Born to Ebola-Infected Mothers After Monoclonal Antibody Therapy
      • Vaccine Innovation Spurred by the Long Wait for an Ebola Virus Vaccine
    • CHEMICAL AND BIOLOGICAL WEAPONS
      • Trump Should Act Against Russia’s Use of Chemical Weapons
      • North Korea and Biological Weapons: Assessing the Evidence
      • Implementing BTWC Article VII: Thoughts for the Meeting of Experts and the Review Conference
      • The Blessing and Curse of Biotechnology: A Primer on Biosafety and Biosecurity
      • Marina Litvinenko Submits €3.5m ECHR Claim Against Russia
      • How Japan Could Have Won World War II
      • Biosecurity in the Wake of COVID-19: The Urgent Action Needed
    • SURVEILLANCE + DETECTION
      • The ‘False-Positive PCR’ Problem Is Not a Problem
      • Three Nations Note H5N8 Avian Flu Outbreaks; Netherlands Finds H5N1 Reassortant
      • The Problem with Repeat COVID-19 Survivor PCR Follow-Up Testing
      • Navy Research Confirms Need for Strict Coronavirus Testing Protocols
      • Comparison of Seven Commercial SARS-Cov-2 Rapid Point-of-Care Antigen Tests
    • COMMENTARY
      • Vaccine Czar Calls on Trump to Allow Contact with Biden
      • First It Was Masks; Now Some Refuse Testing for SARS-CoV-2
      • Iowa’s Covid Wave and the Limits of Personal Responsibility
    • COVID-19 RESOURCE UPDATE

    PUBLIC HEALTH EMERGENCY

    ‘No One Is Listening to Us’

    In the months since March, many have habituated to the horrors of the pandemic, but health-care workers do not have the luxury of looking away. As ICUs fill up across the nation, the toll of the pandemic goes beyond physical exhaustion. COVID-19 has eaten away at the emotional core of their work. The Atlantic

    Now the U.S. Has Lots of Ventilators, but Too Few Specialists to Operate Them

    A burst of production helped the dire shortage that defined the first wave of the coronavirus. Now, many hot spots face a different problem: They have enough ventilators, but not nearly enough workers with the years of training to operate them. NY Times

    Microsoft: Russian, North Korean Hackers Target Vaccine Work

    Microsoft said this week it has detected attempts by state-backed Russian and North Korean hackers to steal valuable data from leading pharmaceutical companies and vaccine researchers. Chinese state-backed hackers have also been targeting vaccine-makers, the U.S. government said in July while announcing criminal charges. Associated Press

    MEDICAL COUNTERMEASURES

    Dec. 10 FDA Panel Could Be Gateway to First EUA of COVID-19 Vaccine

    BioNTech and Pfizer, which submitted their application on Friday, expect to produce globally up to 50 million doses by year-end and up to 1.3 billion doses by YE21, and said they will be able to distribute the vaccine within hours after FDA authorizes it. The companies are applying for authorization of a two-dose regimen. BioCentury

    Virus-like Particle Vaccines: A Prospective Panacea Against an Avian Influenza Panzootic

    Avian influenza viruses rapidly mutate and the available prophylactic vaccines, which are subtype-specific, require frequent updates to be effective against new strains. Chimeric virus-like particle (VLP) vaccines consisting of M2e and/or headless HA have shown the most potential for a universal vaccine to prevent an avian influenza panzootic. Vaccines

    Novavax Posts Massive Coronavirus Vaccine Contract That Government Didn’t Disclose

    A day after Pfizer’s announcement that its COVID-19 vaccine is more than 90% effective, rival Novavax shared its $1.6 billion Operation Warp Speed contract. Notably, the Department of Health and Human Services told NPR in late August that it had “no records” of the Novavax contract. Novavax released its federal contract in a quarterly financial filing with the Securities and Exchange Commission. HHS has yet to release this contract. NPR

    Feds Announce COVID-19 Vaccine Agreement with Drug Stores

    The list of pharmacies joining the distribution partnership include retail chains like Rite Aid and Walgreens, supermarket drug stores like Albertsons and Publix, and big box stores like Costco and Walmart. The agreement to distribute free coronavirus vaccines after they are approved follows a collaboration with CVS and Walgreens to deliver vaccines to nursing homes and administer shots. AP

    Ebola-Negative Neonates Born to Ebola-Infected Mothers After Monoclonal Antibody Therapy

    Few fetuses survive childbirth when the mother is positive for Ebola virus, with almost all being miscarried or stillborn, or dying shortly after birth. This case series reports liveborn neonates to Ebola virus-positive mothers who received investigational monoclonal antibody treatment (mAB114 or REGN-EB3). The Lancet Child & Adolescent Health

    Vaccine Innovation Spurred by the Long Wait for an Ebola Virus Vaccine

    The 2013–16 Ebola virus outbreak—the largest ever recorded—substantially hastened the development of an Ebola virus vaccine. Since then, the safety and efficacy of a recombinant vesicular stomatitis virus (rVSV)-based Ebola virus vaccine was shown, leading to its licensure by the European Medicine Agency in 2019. The Lancet Infectious Diseases

    CHEMICAL AND BIOLOGICAL WEAPONS

    Trump Should Act Against Russia’s Use of Chemical Weapons

    In response to the Navalny attack, the European Union and UK slapped sanctions on six Kremlin, Federal Security Service, and Ministry of Defense officials and one state laboratory they hold responsible for the attack. Yet Russia continues to deny that it possesses or produces Novichok agents. Clearly, more action is needed to deter Russia’s further use of chemical weapons. Defense One

    North Korea and Biological Weapons: Assessing the Evidence

    North Korea’s announcement that it is developing a vaccine for COVID-19 has focused renewed attention on Pyongyang’s purported biological weapons program. While North Korea may once have had and may still be pursuing a BW capability, official US and South Korean public records do not indicate North Korea possesses an advanced BW program. Stimson Center

    Implementing BTWC Article VII: Thoughts for the Meeting of Experts and the Review Conference

    By setting up an institution within the ISU or UN Office for Disarmament Affairs, to which states parties would report immediately any unusual disease outbreak or serious mishap in a biodefence program, states parties would elevate the current confidence-building measures to assurance instruments by making such reporting mandatory. The Trench

    The Blessing and Curse of Biotechnology: A Primer on Biosafety and Biosecurity

    In addition to a lack of verification, the BWC is often perceived by scholars as not readily addressing the impact of emerging technologies, such as synthetic biology and artificial intelligence. Another issue for the BWC is a lack of funding, as many member states have outstanding dues. Carnegie Endowment

    Marina Litvinenko Submits €3.5m ECHR Claim Against Russia

    The widow of Alexander Litvinenko has submitted a claim against Russia to the European court of human rights (ECHR), seeking €3.5m (£3.1m) in compensation for his murder by radiation poisoning in London. A public inquiry concluded that her husband’s murder in 2006 was probably ordered by Vladimir Putin. The submission also asks the Strasbourg judges to rule on the significance of the pattern of targeted assassinations and attempted killings allegedly carried out by Russian state agents across Europe and the Middle East. The Guardian

    How Japan Could Have Won World War II

    During World War II, Japan infamously deployed biological weapons in attacks that infected and killed thousands of Chinese citizens. Less well known, however, is the fact that Japanese strategists also planned to deploy plague bombs against U.S. forces on at least four separate occasions—each only narrowly averted by circumstance. The last such attack, known as Operations Cherry Blossoms at Night, envisioned bombing San Diego with plague-infected fleas.  National Interest and U.S. Naval Institute

    Biosecurity in the Wake of COVID-19: The Urgent Action Needed

    Given the scale of the threat evidenced by the current pandemic, biosecurity needs to be a top priority moving forward. Not only do efforts need to be stepped up to try to prevent the next pandemic (natural or engineered), but resilience needs to be built by developing early warning systems, the capacity to track outbreaks, and medical countermeasures, including “next generation” vaccines. Ideally, efforts need to be globally coordinated, but if this is not possible, a ‘coalition of the willing’ led by the U.S. needs to step up. Combating Terrorism Center at West Point

    SURVEILLANCE + DETECTION

    The ‘False-Positive PCR’ Problem Is Not a Problem

    RNA is a surrogate marker for the amount of virus but not an actual measure because PCR methods can’t tell you a virus is infectious. People are very chuffed to have learned this fact in 2020 by the way. You can tell because they say so. A lot. But despite their newfound out-of-context knowledge they actually know very little about what they’re talking about. Virology Down Under

    Three Nations Note H5N8 Avian Flu Outbreaks; Netherlands Finds H5N1 Reassortant

    In the latest highly pathogenic avian flu developments, three European countries reported more detections in wild birds, including a United Kingdom report of a second outbreak in poultry and a Netherlands detection of an H5N1 reassortant. Germany reported 42 more H5N8 outbreaks in wild birds. CIDRAP

    The Problem with Repeat COVID-19 Survivor PCR Follow-Up Testing

    A JAMA Internal Medicine research letter finds that 18% of recovered COVID-19 patients test positive for SARS-CoV-2, the virus that causes COVID-19, but only 3% (1 of 32) carry replicating virus in their respiratory tract. The practice of repeat testing with highly sensitive RT-PCR which can detect nonviable remnants of the virus following recovery needs further consideration. CIDRAP

    Navy Research Confirms Need for Strict Coronavirus Testing Protocols

    Young, healthy people who contract the coronavirus are often asymptomatic, very rarely need hospital care and can transmit the virus to a roommate unwittingly even when following strict quarantine orders, according to two new studies from the U.S. Navy. The findings support the need for strong measures, like daily testing, that go beyond the temperature checks and symptom reporting now commonly deployed. NY Times

    Comparison of Seven Commercial SARS-Cov-2 Rapid Point-of-Care Antigen Tests

    This study compares 7 available AgPOCT devices against an established RT-PCR assay by conducting a single-center evaluation in a laboratory setting. The aim was to  provide a reflection of test performance based on analytical properties and ease some of the challenges associated with clinical evaluation of AgPOCTs during the present pandemic situation. medRxiv

    COMMENTARY

    Vaccine Czar Calls on Trump to Allow Contact with Biden

    Moncef Slaoui has called on the White House to allow Operation Warp Speed to make contact with Joe Biden’s transition team, warning that interrupting its work would put thousands of lives at risk. ARS Technica

    First It Was Masks; Now Some Refuse Testing for SARS-CoV-2

    Politics, obstinate individualism, fear of isolation and quarantine, potential loss of income…test avoidance appears to be a growing problem, at least anecdotally. Many of the same people who dismiss the need to test feel the same way about wearing a mask, in part because they think no one has the right to tell them to do either. JAMA

    Iowa’s Covid Wave and the Limits of Personal Responsibility

    On Monday night, Iowa governor Kim Reynolds came to her constituents with some surprising news. Along with a series of new restrictions on business operations and social gatherings, she was, for the first time, issuing a state-wide mask mandate. “No one wants to do this. I don’t want to do this,” Reynolds said during the live address. Yes, Iowans were well aware. That was not the surprising part. Wired

    COVID-19 RESOURCE UPDATE

    Courtesy of the CDC Public Health Emergency Preparedness Program Division of State and Local Readiness

    • NEW Late Sequelae of COVID-19
    • NEW COVID-19 Published Science and Research
    • NEW Celebrating Thanksgiving
    • UPDATED CDC COVID-19 Data Tracker
    • UPDATED Staffing Resources
    • UPDATED Long Term Effects of COVID-19
    • UPDATED Investigating the Impact of COVID-19 during Pregnancy
    • UPDATED Clinical Questions about COVID-19: Questions and Answers
    • UPDATED Frequently Asked Questions
    • UPDATED Vaccine Information for You & Your Family
    • UPDATED CDC Science Agenda for COVID-19
    • UPDATED COVID-19 Forecasts: Cases
    • UPDATED COVID-19 Forecasts: Deaths
    • UPDATED Considerations for Wearing Masks
    Editor Pick
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleCOVID-19 Vaccines Were Developed in Record Time – But are These Game-Changers Safe?
    Next Article Testing Sewage Can Give Schools and Businesses a Heads-Up on the Spread of COVID-19

    Related Stories

    EPA Developing AMR Risk Framework for Antibacterial and Antifungal Pesticides

    September 29, 2023

    Provide Feedback on Federal DURC Biosafety Oversight of Potential Pandemic Pathogens

    September 24, 2023

    Committee to Examine Transmission and Geographic Spread of Chronic Wasting Disease

    September 24, 2023

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.